Cubist Systematic Strategies LLC grew its holdings in shares of Cardinal Health Inc (NYSE:CAH) by 392.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 6,894 shares of the company’s stock after purchasing an additional 5,494 shares during the period. Cubist Systematic Strategies LLC’s holdings in Cardinal Health were worth $432,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in the company. Point72 Asset Management L.P. lifted its holdings in shares of Cardinal Health by 244.2% during the first quarter. Point72 Asset Management L.P. now owns 1,266,327 shares of the company’s stock valued at $79,373,000 after purchasing an additional 898,427 shares during the last quarter. Mariner LLC purchased a new position in shares of Cardinal Health during the first quarter valued at approximately $247,000. LPL Financial LLC lifted its holdings in shares of Cardinal Health by 18.2% during the first quarter. LPL Financial LLC now owns 30,719 shares of the company’s stock valued at $1,925,000 after purchasing an additional 4,721 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. lifted its holdings in shares of Cardinal Health by 7.2% during the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 18,987 shares of the company’s stock valued at $1,190,000 after purchasing an additional 1,272 shares during the last quarter. Finally, Natixis lifted its holdings in shares of Cardinal Health by 1,173.8% during the first quarter. Natixis now owns 80,476 shares of the company’s stock valued at $5,044,000 after purchasing an additional 74,158 shares during the last quarter. Hedge funds and other institutional investors own 91.97% of the company’s stock.
Get Cardinal Health alerts:Several equities analysts have recently issued reports on the stock. TheStreet upgraded shares of Cardinal Health from a “c+” rating to a “b-” rating in a report on Tuesday, March 13th. Barclays assumed coverage on shares of Cardinal Health in a report on Thursday, March 8th. They issued an “equal weight” rating and a $74.00 price objective for the company. Zacks Investment Research lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. ValuEngine lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Finally, Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $85.00 price objective for the company in a report on Monday, April 2nd. Five investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $69.79.
Shares of NYSE CAH opened at $49.15 on Tuesday. Cardinal Health Inc has a twelve month low of $48.28 and a twelve month high of $78.89. The company has a market capitalization of $15.17 billion, a P/E ratio of 9.10, a PEG ratio of 1.47 and a beta of 1.01. The company has a quick ratio of 0.54, a current ratio of 1.10 and a debt-to-equity ratio of 1.20.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, May 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.51 by ($0.12). The firm had revenue of $33.63 billion during the quarter, compared to analysts’ expectations of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. sell-side analysts expect that Cardinal Health Inc will post 4.92 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Sunday, July 15th. Shareholders of record on Monday, July 2nd will be paid a dividend of $0.476 per share. The ex-dividend date is Friday, June 29th. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.46. This represents a $1.90 dividend on an annualized basis and a yield of 3.87%. Cardinal Health’s payout ratio is currently 34.26%.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).
No comments:
Post a Comment